CIREX
Price
$83.27
Change
+$0.19 (+0.23%)
Updated
Jul 24 closing price
Net Assets
127.87B
TIBCX
Price
$37.95
Change
-$0.05 (-0.13%)
Updated
Jul 24 closing price
Net Assets
22.78B
Interact to see
Advertisement

CIREX vs TIBCX

CIREX vs TIBCX Comparison Chart in %
View a ticker or compare two or three
VS
CIREX vs. TIBCX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIREX is a Hold and TIBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIREX has more cash in the bank: 128B vs. TIBCX (22.8B). TIBCX (2.55) and CIREX (2.49) have matching dividends . CIREX was incepted earlier than TIBCX: CIREX (24 years) vs TIBCX (24 years). TIBCX (1.90) is less costly to investors than CIREX (0.84). CIREX is a more actively managed with annual turnover of: 50.00 vs. TIBCX (27.78). CIREX has a lower initial minimum investment than TIBCX: CIREX (250) vs TIBCX (5000). TIBCX annual gain was more profitable for investors over the last year : 27.32 vs. CIREX (10.00). TIBCX return over 5 years is better than : 94.93 vs. CIREX (41.46).
CIREXTIBCXCIREX / TIBCX
Total Expense Ratio0.841.9044%
Annual Report Gross Expense Ratio0.841.9044%
Fund Existence24 years24 years-
Gain YTD9.38216.65556%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets128B22.8B561%
Annual Yield % from dividends2.492.5598%
Returns for 1 year10.0027.3237%
Returns for 3 years38.3182.0547%
Returns for 5 years41.4694.9344%
Returns for 10 years89.81156.4857%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LRSVX24.090.04
+0.17%
Lord Abbett Small Cap Value R6
RGBCX42.17-0.01
-0.02%
American Funds Global Balanced R-3
FEMAX15.41-0.06
-0.39%
First Eagle U.S. SMID Cap Opportunity A
KNPCX109.64-1.10
-0.99%
Kinetics Paradigm Adv C
GIRPX13.19-0.35
-2.58%
Goldman Sachs Em Mkts Eq Insghts Inv